Clinical trials

  • ELRANATAMAB for Relapsed/refractory multiple myeloma
  • COPPER SULPHATE, ANHYDROUS; STANNOUS CHLORIDE DIHYDRATE; ZINC CHLORIDE; COBALT CHLORIDE; GOLD SODIUM THIOSULFATE; SODIUM TETRACHLOROPALLADATE; VANADIUM OXIDE SULFATE; AMMONIUM TITANIUM OXALATE MONOHYDRATE; NICKEL SULFATE; MANGANESE CHLORIDE TETRAHYDRATE; KALIUM BICHROMICUM for Allergic contact dermatitis
  • ABBV-453 for Small lymphocytic lymphoma | Chronic lymphocytic leukemia
  • CYCLOPHOSPHAMIDE for ANCA-associated vasculitis
  • GOZETOTIDE for Metastatic hormone-sensitive prostate cancer (mHSPC) | PSMA-positive metastatic hormone-sensitive prostate cancer
  • SETMELANOTIDE for Obesity | Monogenic obesity (POMC/PCSK1/LEPR/NCOA1 (SRC1)/SH2B1 variants)
  • OXYBUTYNIN for Breast cancer
  • Trastuzumab deruxtecan for Metastatic gastric adenocarcinoma
  • Ocrelizumab for Neurological disorder | Multiple sclerosis
  • Lenalidomide for Multiple myeloma
  • Dronabinol, Cannabidiol for Refractory epilepsy
  • TRASTUZUMAB DERUXTECAN for High-risk HER2-positive breast cancer